Dissecting the Role of Single Regions of an IAPP Mimic and IAPP in Inhibition of Aβ40 Amyloid Formation and Cytotoxicity
暂无分享,去创建一个
Andrea Caporale | Erika Andreetto | A. Caporale | A. Kapurniotu | Aphrodite Kapurniotu | E. Andreetto | Li-Mei Yan | Li-mei Yan
[1] Hong Qing,et al. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes , 2010, Neurobiology of Aging.
[2] R. Raffa,et al. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? , 2011, British journal of clinical pharmacology.
[3] M. Shearman,et al. The Intracellular Component of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction Is Specifically Inhibited by β‐Amyloid Peptides , 1995 .
[4] A. Kapurniotu,et al. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt. , 2002, European journal of biochemistry.
[5] Aleksandra Velkova,et al. Amyloid‐Kreuzwechselwirkung zur Inhibierung der Proteinaggregation, nicht aber der Proteinfunktion: Inhibierung der Insulinaggregation im nanomolaren Bereich durch ein IAPP‐Mimetikum , 2008 .
[6] J. Bernhagen,et al. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.
[7] M. Nicolls,et al. The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease. , 2004, Current Alzheimer research.
[8] J. Bernhagen,et al. Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP). , 2000, Chemistry & biology.
[9] Y. Kozutsumi,et al. Cholesterol-dependent Formation of GM1 Ganglioside-bound Amyloid β-Protein, an Endogenous Seed for Alzheimer Amyloid* , 2001, The Journal of Biological Chemistry.
[10] M. Geyer,et al. NMR Spectroscopic Investigation of Early Events in IAPP Amyloid Fibril Formation , 2009, Chembiochem : a European journal of chemical biology.
[11] Li‐Mei Yan,et al. Ein IAPP‐Mimetikum blockiert die zytotoxische Aggregation von Aβ – die Kreuzunterdrückung der Amyloidtoxizität von Aβ und IAPP deutet auf einen molekularen Zusammenhang zwischen Alzheimer‐Krankheit und Typ‐II‐Diabetes hin , 2007 .
[12] C. Dobson. Protein aggregation and its consequences for human disease. , 2006, Protein and peptide letters.
[13] Ronald Wetzel,et al. Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils* , 2004, Journal of Biological Chemistry.
[14] Li‐Mei Yan,et al. Hot‐Spot‐Regionen der Aβ‐IAPP‐Wechselwirkungsdomänen als hochaffine Bindungsstellen bei Kreuz‐ und Selbstassoziation , 2010 .
[15] U Aebi,et al. Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.
[16] A. Kapurniotu,et al. Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[17] Sharon Gilead,et al. Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. , 2002, Journal of molecular biology.
[18] A. Kapurniotu,et al. Exploiting cross-amyloid interactions to inhibit protein aggregation but not function: nanomolar affinity inhibition of insulin aggregation by an IAPP mimic. , 2008, Angewandte Chemie.
[19] A. Kapurniotu,et al. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide. , 2001, Biopolymers.
[20] L. Iversen,et al. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[21] P. Westermark. Aspects on human amyloid forms and their fibril polypeptides , 2005, The FEBS journal.
[22] Ronald Frank,et al. Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association. , 2010, Angewandte Chemie.
[23] Christian Hölscher,et al. Common pathological processes in Alzheimer disease and type 2 diabetes: A review , 2007, Brain Research Reviews.
[24] A. Kapurniotu,et al. IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes. , 2007, Angewandte Chemie.
[25] C. Behl,et al. Amyloid peptides are toxic via a common oxidative mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Westermark,et al. Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid- core-containing hexapeptide. , 2005, Chemistry & biology.
[27] P E Fraser,et al. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. , 2001, Journal of molecular biology.
[28] Eva L. Feldman,et al. How does diabetes accelerate Alzheimer disease pathology? , 2010, Nature Reviews Neurology.
[29] H. Levine. Quantification of beta-sheet amyloid fibril structures with thioflavin T. , 1999, Methods in enzymology.
[30] David Eisenberg,et al. Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process , 2009, Protein science : a publication of the Protein Society.
[31] Fanling Meng,et al. Combination of kinetically selected inhibitors in trans leads to highly effective inhibition of amyloid formation. , 2010, Journal of the American Chemical Society.